Clinical Trial

Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 1, 2025 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a multi-cohort, single-arm, phase II study of the efficacy and side effects of cisplatin plus gemcitabine in the treatment of PD1 failure or intensive treatment of some rare tumors
Trial Details
NCT Number NCT07046650
Lead Sponsor Sheng Zhang
Conditions Advanced Solid Tumors
Enrollment 84 participants
Start Date 2025-01-01
Primary Completion 2026-07-31 (estimated)
Study Completion 2028-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-01